RxDoctor Payments DataLook up a doctor →

Emily Fechner, PA

Physician Assistant · Morton Grove, ILNPI 1669839304

Payments from drug & device makers

$18,446in general payments, 2019–2025

Across 831 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Johnson & Johnson$1K
  • AstraZeneca$871
  • Pfizer$861
  • E.r. Squibb & Sons, L.L.C.$764
  • Amgen$753
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis134$3,217
Johnson & Johnson(2 entities)61$1,322
AstraZeneca(2 entities)32$871
Pfizer51$861
E.r. Squibb & Sons, L.L.C.37$764
Amgen31$753
Merck33$718
Incyte Corporation22$657
Takeda Pharmaceuticals U.S.A., Inc.24$614
AbbVie38$613
Dendreon Pharmaceuticals LLC23$538
Genentech USA, Inc.31$531
Lilly USA, LLC26$450
Seagen Inc.20$436
Bristol Myers Squibb19$434
Sanofi19$427
Regeneron Healthcare Solutions, Inc.14$369
Daiichi Sankyo Inc.19$328
Tersera Therapeutics LLC16$302
Beigene USA, Inc.10$291
Adaptive Biotechnologies Corporation11$261
Pharmacyclics LLC, An Abbvie Company11$244
Jazz Pharmaceuticals Inc.9$235
Gilead(2 entities)8$184
Servier Pharmaceuticals LLC8$174
Blue Earth Diagnostics7$161
Mirati Therapeutics, Inc.6$153
GSK7$149
Pharmacosmos Therapeutics Inc.6$143
EMD Serono, Inc.6$134
Bayer6$130
Blueprint Medicines Corporation4$111
Sobi, Inc5$110
Astellas Pharma US Inc5$107
Morphosys, US Inc.5$107
Agios Pharmaceuticals, Inc.3$106
Eisai Inc.4$100
Deciphera Pharmaceuticals Inc.4$98
Karyopharm Therapeutics Inc.3$81
G1 Therapeutics, Inc.4$75
Alnylam Pharmaceuticals Inc.3$69
Pharmaessentia USA Corporation3$67
EUSA Pharma (US) LLC3$60
Geron Corporation2$58
Novocure Inc.3$58
AVEO Pharmaceuticals, Inc.2$57
Array Biopharma Inc2$53
ADC Therapeutics America, Inc.2$50
CTI Biopharma Corp.2$48
Novo Nordisk2$47
Intera Oncology, Inc1$43
Tempus AI, Inc2$40
AMAG Pharmaceuticals, Inc.2$38
Acrotech Biopharma Inc.2$36
Boehringer Ingelheim1$31
Menarini Silicon Biosystems, Inc.2$30
Stemline Therapeutics Inc.1$28
Kyowa Kirin, Inc.1$24
Taiho Oncology, Inc.1$24
Exelixis Inc.1$22

How this compares

$18,446 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$578,750
Medicare patients
182
Services billed
26,769

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Morton Grove

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →